Medical Marijuana Clinical Studies

Over the years the clinical research and trials conducted around marijuana have produced many noteworthy results and researchers have found them as a very significant treatment option. Worldwide numerous clinical trials are going to evaluate the safety, and effectiveness of medical marijuana for a number of diseases such as ChronicPain, Cachexia, Epilepsy, multiple sclerosis, Anxiety, and many others.

Apart from these, a significant number of studies are going on to access the impact of medical marijuana on Peripheral Neuropathy, Chemotherapy-induced Peripheral Neuropathy, Huntington’s Disease, Irritable Bowel Syndrome, Schizophrenia, Psychosis, Glaucoma, and so many others.

The key companies in the medical marijuana markets include Cannabics Pharmaceuticals, GSK, Tilray, GW Pharmaceuticals, OTSUKA PHARMACEUTICALS, Aurora Cannabis, Tetra Bio-Pharma, and many others.

For more details, visit: https://www.delveinsight.com/blog/medical-marijuana-clinical-trials/